A promising vaccine candidate, new mutual-aid networks, and more COVID-19 updates

A roundup of the top stories you may have missed this week.

The coronavirus crisis is unique. Addressing it will require new ideas, new perspectives, and new voices. That’s our mission at Freethink.

In our weekly “Coronavirus News Roundup,” we’re highlighting the most important stories from the frontlines of the fight against COVID-19. Stories that inform, challenge, and inspire.

Here are our must reads for today, April 4, 2020.

1. Pitt Unveils New Vaccine Candidate That Creates Antibodies in Mice

This week, a promising new candidate emerged in the global hunt for an effective coronavirus vaccine — and it comes in the form of a microneedle patch. We explore why this unique delivery method could make the vaccine easier to scale-up.

2. Colorado Launches Antibody Testing Project That Could Help End Lockdown

Colorado’s San Miguel County has launched a first-of-its-kind coronavirus antibody testing project — and it could ensure life in places disrupted by the COVID-19 outbreak returns to normal as soon as possible.

3. Researchers Join Forces to Protect Workers Reusing N95 Masks

Until the shortage of new N95 masks is resolved, healthcare workers are going to continue to reuse the ones they have — and the efforts of the people highlighted in this article will help ensure they do so in the safest way possible.

4. Silicon Valley Fixes Hundreds of Broken Ventilators for California Hospitals

Working ventilators for coronavirus patients are in short supply — so engineers from San Jose’s Bloom Energy have taught themselves how to refurbish and repair old ones for the state of California.

5. Volunteers Use Tech to Help Their Communities During the Coronavirus Pandemic

Thousands of volunteers across the globe are joining forces to support the most vulnerable members of their communities during the coronavirus pandemic — and they’re doing so with more than a little help from modern technology.

Related
Revolutionary weight-loss drugs like Wegovy come with a catch
People taking GLP-1 agonists are losing too much muscle, but these drugs designed to prevent muscle loss could solve the problem.
Are weight-loss meds the next wonder drugs?
Evidence is mounting that GLP-1 agonists could treat many health issues — including ones that aren’t obviously related to weight.
Milk could overcome one of the biggest hurdles to RNA therapies
RNA therapies typically break down if administered orally, but particles found in cows’ milk could provide perfect protection.
See how Moderna is using OpenAI tech across its workforce
A partnership between Moderna and OpenAI provides a real-world example of what can happen when a company leans into generative AI.
Scientists have invented a method to break down “forever chemicals” in our drinking water
Researchers have discovered a way to eliminate “forever chemicals,” or PFAS, which usually take hundreds or thousands of years to break down.
Up Next
New Coronavirus Vaccine
Subscribe to Freethink for more great stories